Ligand Pharmaceuticals Stock Forecast - Naive Prediction

LGND Stock  USD 206.81  0.16  0.08%   
The Naive Prediction forecasted value of Ligand Pharmaceuticals Incorporated on the next trading day is expected to be 204.11 with a mean absolute deviation of 4.27 and the sum of the absolute errors of 264.48. Ligand Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Ligand Pharmaceuticals stock prices and determine the direction of Ligand Pharmaceuticals Incorporated's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Ligand Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the rsi of Ligand Pharmaceuticals' share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Ligand Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Ligand Pharmaceuticals and does not consider all of the tangible or intangible factors available from Ligand Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Ligand Pharmaceuticals Incorporated, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Ligand Pharmaceuticals' stock price prediction:
Quarterly Earnings Growth
1.032
EPS Estimate Next Quarter
2.03
EPS Estimate Current Year
7.58
EPS Estimate Next Year
8.4157
Wall Street Target Price
243.4444
Using Ligand Pharmaceuticals hype-based prediction, you can estimate the value of Ligand Pharmaceuticals Incorporated from the perspective of Ligand Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Ligand Pharmaceuticals using Ligand Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Ligand using crowd psychology based on the activity and movement of Ligand Pharmaceuticals' stock price.

Ligand Pharmaceuticals Short Interest

A significant increase or decrease in Ligand Pharmaceuticals' short interest from the previous month could be a good indicator of investor sentiment towards Ligand. Short interest can provide insight into the potential direction of Ligand Pharmaceuticals stock and how bullish or bearish investors feel about the market overall.
200 Day MA
150.269
Short Percent
0.0765
Short Ratio
6
Shares Short Prior Month
1.1 M
50 Day MA
196.2992

Ligand Pharmaceuticals Hype to Price Pattern

Investor biases related to Ligand Pharmaceuticals' public news can be used to forecast risks associated with an investment in Ligand. The trend in average sentiment can be used to explain how an investor holding Ligand can time the market purely based on public headlines and social activities around Ligand Pharmaceuticals Incorporated. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Ligand Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Ligand Pharmaceuticals.

Ligand Pharmaceuticals Implied Volatility

    
  0.65  
Ligand Pharmaceuticals' implied volatility exposes the market's sentiment of Ligand Pharmaceuticals Incorporated stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Ligand Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Ligand Pharmaceuticals stock will not fluctuate a lot when Ligand Pharmaceuticals' options are near their expiration.
The Naive Prediction forecasted value of Ligand Pharmaceuticals Incorporated on the next trading day is expected to be 204.11 with a mean absolute deviation of 4.27 and the sum of the absolute errors of 264.48.

Ligand Pharmaceuticals after-hype prediction price

    
  USD 206.05  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Ligand Pharmaceuticals to cross-verify your projections.
At present, Ligand Pharmaceuticals' Receivables Turnover is projected to slightly decrease based on the last few years of reporting. The current year's Asset Turnover is expected to grow to 0.32, whereas Inventory Turnover is forecasted to decline to 0.67. . As of January 13, 2026, Common Stock Shares Outstanding is expected to decline to about 16.3 M. The current year's Net Loss is expected to grow to about (36.4 M).

Open Interest Against 2026-02-20 Ligand Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Ligand Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Ligand Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Ligand Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Ligand Pharmaceuticals' open interest, investors have to compare it to Ligand Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Ligand Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Ligand. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.

Ligand Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Ligand price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ligand using various technical indicators. When you analyze Ligand charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Ligand Pharmaceuticals Cash Forecast

Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Ligand Pharmaceuticals' financial statements to predict how it will affect future prices.
 
Cash  
First Reported
1994-03-31
Previous Quarter
67.7 M
Current Value
139.4 M
Quarterly Volatility
240.2 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
A naive forecasting model for Ligand Pharmaceuticals is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Ligand Pharmaceuticals Incorporated value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Ligand Pharmaceuticals Naive Prediction Price Forecast For the 14th of January 2026

Given 90 days horizon, the Naive Prediction forecasted value of Ligand Pharmaceuticals Incorporated on the next trading day is expected to be 204.11 with a mean absolute deviation of 4.27, mean absolute percentage error of 24.70, and the sum of the absolute errors of 264.48.
Please note that although there have been many attempts to predict Ligand Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Ligand Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Ligand Pharmaceuticals Stock Forecast Pattern

Backtest Ligand PharmaceuticalsLigand Pharmaceuticals Price PredictionBuy or Sell Advice 

Ligand Pharmaceuticals Forecasted Value

In the context of forecasting Ligand Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Ligand Pharmaceuticals' downside and upside margins for the forecasting period are 202.06 and 206.16, respectively. We have considered Ligand Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
206.81
202.06
Downside
204.11
Expected Value
206.16
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Ligand Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Ligand Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria123.1552
BiasArithmetic mean of the errors None
MADMean absolute deviation4.2658
MAPEMean absolute percentage error0.0219
SAESum of the absolute errors264.4811
This model is not at all useful as a medium-long range forecasting tool of Ligand Pharmaceuticals Incorporated. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Ligand Pharmaceuticals. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Ligand Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ligand Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
204.00206.05208.10
Details
Intrinsic
Valuation
LowRealHigh
186.13223.06225.11
Details
7 Analysts
Consensus
LowTargetHigh
221.53243.44270.22
Details
Earnings
Estimates (0)
LowProjected EPSHigh
1.541.822.15
Details

Other Forecasting Options for Ligand Pharmaceuticals

For every potential investor in Ligand, whether a beginner or expert, Ligand Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Ligand Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Ligand. Basic forecasting techniques help filter out the noise by identifying Ligand Pharmaceuticals' price trends.

Ligand Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ligand Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Ligand Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Ligand Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Ligand Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Ligand Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Ligand Pharmaceuticals' current price.

Ligand Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Ligand Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ligand Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Ligand Pharmaceuticals stock market strength indicators, traders can identify Ligand Pharmaceuticals Incorporated entry and exit signals to maximize returns.

Ligand Pharmaceuticals Risk Indicators

The analysis of Ligand Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Ligand Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting ligand stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Ligand Pharmaceuticals is a strong investment it is important to analyze Ligand Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ligand Pharmaceuticals' future performance. For an informed investment choice regarding Ligand Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Ligand Pharmaceuticals to cross-verify your projections.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ligand Pharmaceuticals. If investors know Ligand will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ligand Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.032
Earnings Share
2.27
Revenue Per Share
13.038
Quarterly Revenue Growth
1.228
Return On Assets
0.0148
The market value of Ligand Pharmaceuticals is measured differently than its book value, which is the value of Ligand that is recorded on the company's balance sheet. Investors also form their own opinion of Ligand Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Ligand Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ligand Pharmaceuticals' market value can be influenced by many factors that don't directly affect Ligand Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ligand Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ligand Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ligand Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.